ATP1A3‐Related Relapsing Encephalopathy with Cerebellar Ataxia (RECA): A Genetic Disorder with an Inflammatory Basis?
- 30 September 2022
- journal article
- research article
- Published by Wiley in Movement Disorders Clinical Practice
- Vol. 9 (8) , 1120-1123
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Cerebrospinal fluid neopterin as a biomarker of neuroinflammatory diseasesScientific Reports, 2020
- Relapsing encephalopathy with cerebellar ataxia are caused by variants involving p.Arg756 in ATP1A3European Journal of Paediatric Neurology, 2019
- ATP1A3-related disorders: An updateEuropean Journal of Paediatric Neurology, 2018
- Fever-Induced Paroxysmal Weakness and Encephalopathy, a New Phenotype of ATP1A3 MutationPediatric Neurology, 2017
- Mosaicism in ATP1A3-related disorders: not just a theoretical riskneurogenetics, 2016
- Relapsing encephalopathy with cerebellar ataxia related to an ATP1A3 mutationDevelopmental Medicine & Child Neurology, 2015
- Excellent Response to a Ketogenic Diet in a Patient with Alternating Hemiplegia of Childhood2014
- Alternating Hemiplegia of Childhood With a de Novo Mutation in ATP1A3 and Changes in SLC2A1 Responsive to a Ketogenic DietPediatric Neurology, 2013
- Cerebrospinal fluid neopterin in paediatric neurology: a marker of active central nervous system inflammationDevelopmental Medicine & Child Neurology, 2009
- Increased neopterin production and tryptophan degradation in advanced Parkinson's diseaseJournal of Neural Transmission, 2002